SYNG Pharma Partners with Impact Centre to Develop Endometriosis Diagnostic

Ontario Industry Updates
Written By Guest User

Syng Pharmaceuticals is working with the Impact Centre to develop a new non-invasive diagnostic test for endometriosis, an immunologic condition affecting one in ten women.

Click here for more information

Guest User
Previous

Vasomune Therapeutics Appoints Douglas A. Hamilton as President and Chief Executive Officer

Next

Cyclica Announces Collaboration with Eurofarma